# Cadeler A/S: financial statements, quarterly

CDLR · NYSE · CIK 1978867 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdlr.md) · [Financials](/companies/cdlr/financials.md) · [Filings](/companies/cdlr/filings.md) · [Insiders](/companies/cdlr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cdlr/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2020-12-31) | period not labelled (2021-12-31) | period not labelled (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [63.6](/filings/0001104659-24-038836.md) | [2.3](/filings/0001104659-25-027667.md) | [19.0](/filings/0001978867-26-000022.md) | [96.6](/filings/0001978867-26-000022.md) | [51.3](/filings/0001978867-26-000022.md) | [152](/filings/0001978867-26-000022.md) |
| Current assets | $m | not reported | [24.6](/filings/0001104659-24-038836.md) | [59.5](/filings/0001104659-25-027667.md) | [147](/filings/0001978867-26-000022.md) | [181](/filings/0001978867-26-000022.md) | [390](/filings/0001978867-26-000022.md) |
| Total assets | $m | not reported | [425](/filings/0001104659-24-038836.md) | [670](/filings/0001104659-25-027667.md) | [1,253](/filings/0001978867-26-000022.md) | [1,937](/filings/0001978867-26-000022.md) | [3,417](/filings/0001978867-26-000022.md) |
| Current liabilities | $m | not reported | [53.9](/filings/0001104659-24-038836.md) | [11.8](/filings/0001104659-25-027667.md) | [53.6](/filings/0001978867-26-000022.md) | [124](/filings/0001978867-26-000022.md) | [351](/filings/0001978867-26-000022.md) |
| Total liabilities | $m | not reported | [99.5](/filings/0001104659-24-038836.md) | [129](/filings/0001104659-25-027667.md) | [294](/filings/0001978867-26-000022.md) | [703](/filings/0001978867-26-000022.md) | [1,913](/filings/0001978867-26-000022.md) |
| Shareholders' equity | $m | [241](/filings/0001104659-24-038836.md) | [325](/filings/0001104659-25-027667.md) | [541](/filings/0001978867-26-000022.md) | [959](/filings/0001978867-26-000022.md) | [1,234](/filings/0001978867-26-000022.md) | [1,504](/filings/0001978867-26-000022.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 350,957,583 at 2025-12-31, from the cover of the [20-F filed 2026-03-24](/filings/0001978867-26-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.